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(S)-Selective MenD variants from Escherichia coli
provide access to new functionalized chiral a-hydroxy
ketones†
Robert Westphal,a Simon Waltzer,b Ursula Mackfeld,a Michael Widmann,c
Ju¨rgen Pleiss,c Maryam Beigi,b Michael Mu¨ller,b Do¨rte Rothera and Martina Pohl*a
We report the first rationally designed (S)-selective MenD from
E. coli for the synthesis of functionalized a-hydroxy ketones. By
mutation of two amino acids in the active site stereoselectivity of
the (R)-selective EcMenD (ee > 93%) was inverted giving access to
(S)-5-hydroxy-4-oxo-5-phenylpentanoate derivatives with stereo-
selectivities up to 97% ee.
Optically active a-oxyfunctionalized carbonyl compounds are
valuable synthetic building blocks in preparative organic
chemistry.1 Among them, a-hydroxy ketones are of particular
value for the pharmaceutical as well as the fine chemistry
sector.2 In addition, a-hydroxy ketones are putative precursors
of 2-amino alcohols, or 1,2-diols, among others.3,4 Various
non-enzymatic routes to chiral a-hydroxy ketones have been
reported including organocatalytic strategies.5,6 However, high
stereoselectivities are rare. Furthermore, most of the syntheses
require several steps, which impair the overall yields.2
Thiamine diphosphate (ThDP)-dependent enzymes are well
known for their catalytic potential to form various a-hydroxy
ketones. The mechanism has been studied extensively7 and
several ThDP-dependent lyases, such as pyruvate decarboxylases,
branched-chain keto acid decarboxylase, benzoylformate
decarboxylase, and benzaldehyde lyase, have been already
characterized as powerful catalysts.8 As most of the wild type
(wt) enzymes are (R)-selective, access to (S)-a-hydroxy ketones is
limited. Structural basis for stereoselectivity has been investi-
gated with the benzoylformate decarboxylase from Pseudomonas
putida, which shows (S)-selectivity in the carboligation of
benzaldehyde and acetaldehyde.9,10 The study revealed a
structural element called ‘‘S-pocket’’, which allows an
antiparallel arrangement of donor and acceptor substrates, the
prerequisite for (S)-selectivity.11 S-pockets are present in most of
the (R)-selective enzymes, however, not accessible to acceptor
substrates due to large amino acid side chains.12,13
The ThDP-dependent enzyme 2-succinyl-5-enolpyruvyl-6-
hydroxy-3-cyclohexene-1-carboxylate synthase from Escherichia
coli (EcMenD) catalyzes the second step in the biosynthesis of
menaquinones.14 The carboligation potential of EcMenD has
recently been characterized concerning substrate diversity and
stereoselectivity.15,16 EcMenD uses a-ketoglutarate (1) as the
physiological donor, which is extraordinary among ThDP-
dependent enzymes. This enables selective C4 chain elongation
with a terminal carboxyl group. EcMenD accepts a broad range of
aldehydes as acceptors. Carboligation of 1 (upon decarboxylation)
with different aromatic aldehydes gives a-hydroxy ketones with
high enantiomeric excesses (ee) of >93% (R).16 Here, we report the
first rationally designed EcMenD variants for the syntheses of
functionalized (S)-a-hydroxy ketones starting from 1 and differently
substituted benzaldehyde derivatives 2.
We combined rational protein engineering with substrate
engineering to get access to functionalized (S)-a-hydroxy
ketones. Important residues of the S-pocket were identified
based on the crystal structure of EcMenD (2JLC).17 Using docking
studies (see ESI†) with benzaldehyde (2a), two residues were
deduced to be crucial for stereoselectivity: I474 and F475 prevent
the antiparallel arrangement of 2a prior to C–C-bond formation.
This explains the high (R)-selectivity of 99% ee of the wt enzyme in
the carboligation reaction with 1 (Scheme 1A). Hence, in order to
gain sufficient space for the phenyl ring of 2a, both I474 and F475
were mutated to glycine and alanine, respectively.
Four variants were prepared: I474G/F475G, I474G/F475A,
I474A/F475G, and I474A/F475A. In all cases, the formation
of (S)-5-hydroxy-4-oxo-5-phenylpentanoate (3a) was observed.
Whereas variants I474G/F475G and I474G/F475A showed only
low selectivity for the formation of (S)-3a (ee 34% and ee 27%),
the variants I474A/F475A and I474A/F475G revealed higher
(S)-selectivities of 66% ee and 75% ee, respectively. Thus, the
S-pocket could be opened such that 2a was able to arrange
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predominantly in an antiparallel orientation relative to the
ThDP-bound donor aldehyde (Scheme 1B). Consequently, the
results support the previously developed S-pocket concept.11,12
Besides accessibility of the S-pocket, optimal stabilization of
the acceptor 2a is crucial for high stereoselectivity. Best stabili-
zation of antiparallely oriented 2a seemed to be achieved in
I474A/F475G. However, the catalytic activity, which may be
estimated from the conversions of the EcMenD variants, was
lower compared to the wt enzyme (Table 1). Whereas I474G/
F475A and I474A/F475A still showed a good conversion of 67%
and 68%, respectively, variants I474G/F475G and I474A/F475G
revealed only 26% and 15% conversion after 24 h under the
tested conditions. Mutation of two adjacent amino acids in the
active site might destabilize the binding of the substrate, in
which the introduction of glycine at position 475 seemed to
have a significant influence on the conversion.
The full catalytic potential of the three best (S)-selective
EcMenD variants I474G/F475G, I474A/F475G, and I474A/F475A
was explored in the next step. Various ortho-, meta-, and
para-substituted benzaldehydes were tested beginning with
fluoro- and chlorobenzaldehydes (2b–g). As expected, stereo-
selectivity was affected with all substrates compared to the high
(R)-selectivity of EcMenDwt (ee > 93%, Table 1). EcMenD
variants showed the following trends: all tested ortho- and
para-substituted benzaldehyde derivatives resulted in a higher
amount of the (R)-enantiomer compared to 2a, while the meta-
substituted benzaldehydes led to higher (S)-selectivity relative
to 2a. Under non-optimized experimental conditions lowest
conversions of o24% were observed for para-substituted
derivatives 2d and 2g, which might be a consequence of weak
substrate stabilization in the active site concomitant with low
conversion rates. Compared to the para-substituted benzalde-
hydes higher conversions of 31–76% were observed with ortho-
substituted derivatives. As in both cases the (R)-enantiomers
are predominantly formed, a sub-optimal stabilization of ortho-
and para-substituted benzaldehydes in the S-pockets of the
three tested EcMenD variants can be deduced. Remarkable
results were obtained with meta-substituted benzaldehydes as
acceptors: (S)-selectivity as well as conversion could be
enhanced significantly with all variants compared to benzalde-
hyde 2a as the acceptor. Employing 2c and especially 2f stereo-
selectivities of 59–89% ee (S) and conversions of 43–94% were
obtained. Consequently, the nature of the substrate plays an
important role. As meta-substituted benzaldehyde derivatives
seem to be highly beneficial for (S)-selective carboligation using
EcMenD variants, 2h–2j were also tested in the carboligation
with 1. Whereas substrate 2j was also highly (S)-selectively
transformed with an ee of 78–93%, the most striking result
was obtained with 2h and 2i. With these substrates an almost
complete inversion of stereoselectivity was possible, connected
with high conversions of >86% under the tested conditions. For
instance, I474A/F475A catalyzes the formation of 3h with
complete conversion and an ee of 95% (S). In order to examine
Scheme 1 Inversion of the stereoselectivity of wt EcMenD by structure-based
design of the active site.
Table 1 Carboligation of a-ketoglutarate (1) and differently substituted benzaldehydes (2) to functionalized chiral a-hydroxy ketones (3) by EcMenDwt and variantsa
Product R2 R3 R4 R5
wt I474G/F475G I474A/F475A I474A/F475G
Conv.b (%) eec (%) Conv.b (%) eec (%) Conv.b (%) eec (%) Conv.b (%) eec (%)
3a H H H H >99 >99 (R) 26 34 (S) 68 66 (S) 15 75 (S)
3b F H H H >99 94 (R) 66 r5 76 20 (S) 55 48 (S)
3c H F H H >99 96 (R) 58 59 (S) 75 80 (S) 43 82 (S)
3d H H F H >99 99 (R) 10 32 (R) 24 30 (S) 14 46 (S)
3e Cl H H H 98 93 (R) 31 70 (R) 66 40 (R) 57 r5
3f H Cl H H >99 96 (R) 75 85 (S) 82 88 (S) 94 89 (S)
3g H H Cl H >99 93 (R) 21 89 (R) 12 70 (R) 15 48 (R)
3h H Br H H 99 99 (R) 99 94 (S) 99 95 (S) 87 97 (S)
3i H I H H >99 94 (R) >99 91 (S) 99 93 (S) 86 93 (S)
3j H OCH3 H H 99 >99 (R) 99 78 (S) 89 87 (S) 64 93 (S)
3k H OCH3 H OCH3 99 98 (R) 99 85 (S) 98 96 (S) 83 96 (S)
a Carboligation reaction was performed in 50 mM potassium phosphate buffer, pH 8.0, (2 mMMgSO4, 0.1 mM ThDP, and 5 vol% MTBE) with 0.70
mg of the respective EcMenD variant at 30 1C and 300 rpm for 24 h using 50 mM a-ketoglutarate (1) and 20 mM benzaldehyde derivatives (2a–k).
b Conversion was determined by GC-MS [DB-5MS Agilent] based on benzaldehyde consumption. c Determined by chiral HPLC analysis using a
Chiralpak IC, and Chiralcel OB and OD-H, respectively. The absolute configuration was determined by circular dichroism.
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the full potential of the S-pocket, 3,5-di-methoxybenzaldehyde
(2k) was finally tested. The results obtained with variants I474A/
F475G and I474A/F475A, which catalyze the formation of (S)-3k
with an ee of 96% and conversions of >83%, demonstrate that
even this bulky substrate was able to enter the S-pocket
properly.
The designed S-pocket of the EcMenD variants seems to be
tailored for meta-substituted benzaldehydes. High stereo-
selectivities as well as high conversions suggested good stabili-
zation of the acceptor in the S-pocket. Furthermore, the parallel
acceptor orientation, leading to the respective (R)-product,
might be destabilized, too (Scheme 1). Reaction engineering
might further improve stereoselectivities and conversions. To
explain these results as well as the selectivities with ortho- and
para-substituted substrates, structural studies with these
(S)-selective EcMenD variants are currently underway. Together
with molecular dynamics simulations of the binding states
(parallel and antiparallel orientation of the acceptor), we want
to get a deeper insight into EcMenD selectivity and carboliga-
tion activity. Furthermore, we want to explore the scope of
EcMenD catalysis with other acceptor substrates, e.g. aliphatic
aldehydes.
In conclusion, we have rationally designed the first MenD
variants as powerful biocatalysts for the (S)-selective synthesis
of functionalized a-hydroxy ketones starting from differently
substituted benzaldehydes. Mutation of two amino acids in the
active site could invert the stereoselectivity of the wt enzyme for
most of the investigated substrates. Particularly the use of
meta-substituted substrates resulted in high (S)-selectivities
accompanied by good to excellent conversions. Therewith, we
provide access to new, yet not reported (S)-5-hydroxy-4-oxo-5-
phenylpentanoate derivatives.
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